Super Bowl ad for Hims & Hers' weight loss drug sparks backlash
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers: Firing On All Cylinders, But Expensive
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
Hims & Hers Option Trade Offers $410 Return Or 17% Discount
The goal is to either have the put expire worthless and keep the premium, or to be assigned and acquire the stock below the ...
Why Hims & Hers Terrifies Big Pharma
Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified wha ...
FiercePharma1h
‘We cannot stay silent’: Novo Nordisk flags dangers of compounded GLP-1s following Hims & Hers Super Bowl ad
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
HIMS stock soars to all-time high, reaching $46.11
In a remarkable display of market confidence, HIMS & Hers Health, Inc. (HIMS) stock has soared to an all-time high, with shares hitting a peak of $46.11. This milestone underscores the company's ...
The complicated world of compounded weight-loss drugs
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...
healthday48m
Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are ca ...
The Miami Hurricane2h
The NFL fumbled by airing the controversial ‘Hims & Hers’ commercial
By: Katie Karlson and Madeline Darby Super Bowl commercials have been a cultural phenomenon for years. However, this year, one commercial sparked widespread controversy and a heated debate about the ...